HSBC Holdings’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $208K | Sell |
707
-2,987
| -81% | -$967K | ﹤0.01% | 2597 |
|
|
2025
Q4 | $1.12M | Buy |
3,694
+2,377
| +180% | +$778K | ﹤0.01% | 1870 |
|
|
2025
Q3 | $448K | Sell |
1,317
-19,322
| -94% | -$5.87M | ﹤0.01% | 2160 |
|
|
2025
Q2 | $4.99M | Buy |
20,639
+5,046
| +32% | +$1.24M | ﹤0.01% | 1153 |
|
|
2025
Q1 | $4.14M | Buy |
15,593
+12,514
| +406% | +$2.93M | ﹤0.01% | 1172 |
|
|
2024
Q4 | $569K | Sell |
3,079
-18,291
| -86% | -$3.74M | ﹤0.01% | 2099 |
|
|
2024
Q3 | $4.78M | Sell |
21,370
-2,811
| -12% | -$506K | ﹤0.01% | 1131 |
|
|
2024
Q2 | $3.45M | Sell |
24,181
-14,013
| -37% | -$2.16M | ﹤0.01% | 1192 |
|
|
2024
Q1 | $5.97M | Buy |
38,194
+6,416
| +20% | +$1.03M | ﹤0.01% | 1035 |
|
|
2023
Q4 | $5.72M | Sell |
31,778
-33,685
| -51% | -$6.09M | 0.01% | 1104 |
|
|
2023
Q3 | $11.8M | Buy |
65,463
+23,744
| +57% | +$4.7M | 0.01% | 779 |
|
|
2023
Q2 | $7.44M | Buy |
41,719
+4,581
| +12% | +$1.05M | 0.01% | 910 |
|
|
2023
Q1 | $8M | Sell |
37,138
-14,052
| -27% | -$3.37M | 0.01% | 940 |
|
|
2022
Q4 | $11.3M | Sell |
51,190
-34,585
| -40% | -$6.34M | 0.01% | 890 |
|
|
2022
Q3 | $11.6M | Sell |
85,775
-20,452
| -19% | -$3.51M | 0.02% | 784 |
|
|
2022
Q2 | $17.3M | Buy |
106,227
+22,914
| +28% | +$3.58M | 0.02% | 628 |
|
|
2022
Q1 | $15.8M | Buy |
83,313
+8,083
| +11% | +$1.72M | 0.02% | 680 |
|
|
2021
Q4 | $20.5M | Sell |
75,230
-1,133
| -1% | -$383K | 0.02% | 663 |
|
|
2021
Q3 | $27.9M | Buy |
76,363
+4,536
| +6% | +$1.48M | 0.03% | 517 |
|
|
2021
Q2 | $24.8M | Buy |
71,827
+28,215
| +65% | +$9.35M | 0.03% | 557 |
|
|
2021
Q1 | $15.2M | Sell |
43,612
-14,357
| -25% | -$4.75M | 0.02% | 683 |
|
|
2020
Q4 | $15M | Sell |
57,969
-418,864
| -88% | -$115M | 0.02% | 668 |
|
|
2020
Q3 | $137M | Sell |
476,833
-257,045
| -35% | -$60.4M | 0.22% | 78 |
|
|
2020
Q2 | $138M | Sell |
733,878
-6,231
| -0.8% | -$1.01M | 0.26% | 69 |
|
|
2020
Q1 | $91.1M | Buy |
740,109
+325,943
| +79% | +$51M | 0.21% | 96 |
|
|
2019
Q4 | $68.6M | Buy |
414,166
+351,362
| +559% | +$58.4M | 0.12% | 158 |
|
|
2019
Q3 | $7.69M | Buy |
62,804
+6,086
| +11% | +$808K | 0.01% | 979 |
|
|
2019
Q2 | $7.03M | Sell |
56,718
-2,340
| -4% | -$297K | 0.01% | 1003 |
|
|
2019
Q1 | $7.79M | Buy |
59,058
+53,785
| +1,020% | +$7.26M | 0.01% | 932 |
|
|
2018
Q4 | $740K | Sell |
5,273
-2,623,145
| -100% | -$348M | ﹤0.01% | 1942 |
|
|
2018
Q3 | $453M | Buy |
2,628,418
+2,428,418
| +1,214% | +$408M | 0.73% | 16 |
|
|
2018
Q2 | $30.7M | Buy |
200,000
+100,000
| +100% | +$17.8M | 0.05% | 352 |
|
|
2018
Q1 | $16.8M | Buy |
+100,000
| New | +$13.5M | 0.03% | 621 |
|
|
2017
Q1 | – | Sell |
-21,178
| Closed | -$643K | – | 2633 |
|
|
2016
Q4 | $643K | Buy |
21,178
+266
| +1% | +$8.36K | ﹤0.01% | 1644 |
|
|
2016
Q3 | $636K | Buy |
+20,912
| New | +$607K | ﹤0.01% | 1487 |
|
Other funds holding ONC
BBA
HA
HSBC Holdings's ONC Position: Q1 2026 in Review
HSBC Holdings reduced its BeOne Medicines Ltd (ONC) stake by 81% in Q1 2026, selling an estimated $967K and leaving 707 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.
HSBC Holdings first reported a position in ONC in Q3 2016 and has held it in 35 quarters since. The position peaked at $453M in Q3 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- HSBC Holdings held 707 shares of BeOne Medicines Ltd worth $208K as of Q1 2026.
- HSBC Holdings sold 2,987 BeOne Medicines Ltd shares in Q1 2026, an estimated $967K.
- BeOne Medicines Ltd made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2597 holding.
- HSBC Holdings first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 35 quarters since.
- HSBC Holdings's BeOne Medicines Ltd position peaked at $453M in Q3 2018.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.